Latest Delorean (ASX:DEL) News

Small-cap shares delivered the week’s biggest moves, led by Mamba’s exploration funding and Cettire’s rebound. Clinical failures, cash shortages and delayed projects kept the broader market cautious.

Delorean Corporation’s SA1 Salisbury renewable gas project is more than 85% complete after the company returned to near break-even EBITDA in FY2026. But the annual report carries a material uncertainty over going concern, leaving commissioning, refinancing and new funding as critical tests for the ASX-listed developer.

Delorean Corporation and Opal have completed the concept stage for a proposed anaerobic digestion facility at Opal’s Maryvale Mill in Victoria. The project could replace natural gas used by the mill’s rotary lime kiln, but still requires further engineering, commercial work and a final investment decision.

Delorean Corporation has received a $1.66 million milestone payment from ARENA, advancing its SA1 Salisbury bioenergy facility towards renewable gas production and multiple revenue streams.

Delorean Corporation’s SA1 Salisbury bioenergy project has secured accreditation under GreenPower’s Renewable Gas Certification, enabling it to issue Renewable Gas Guarantee of Origin certificates and strengthen its role in Australia’s renewable gas market.

Delorean Corporation has closed its Share Purchase Plan, raising $750,000 through the issue of over 8.3 million shares at $0.09 each, supplementing earlier strategic funding from LMS Energy.

Delorean’s flagship SA1 Salisbury bioenergy plant is 75% complete, poised to start injecting renewable biomethane into Adelaide’s gas network by November 2026, marking a first in Australia for commercial and industrial organic waste processing.

Delorean Corporation has banked a $5.76 million cash refund from the Australian Government’s FY2025 R&D Tax Incentive, underpinning its bioenergy infrastructure growth. Another refund linked to FY2026 expenditure is anticipated next year.

Delorean Corporation has launched a $2.2 million Share Purchase Plan at $0.09 per share, matching a recent strategic placement to LMS Energy. The capital raise supports construction of key bioenergy projects in South Australia and New South Wales.

Delorean Corporation reported solid progress in Q3 FY2026, including a positive Final Investment Decision for its NSW1 Horsley Park bioenergy facility backed by $30.5 million in grants, alongside ongoing construction at its flagship SA1 Salisbury project.

Rare earths, lithium and antimony stocks drove the week, while a handful of capital raisings and profit warnings hit hard. The biggest gains came from drilling wins and deal news. The sharpest falls came where investors faced dilution, weaker earnings or takeover friction.

Delorean Corporation has approved the Final Investment Decision for its 100% owned NSW1 Horsley Park Bioenergy Facility, supported by $30.5 million in grants. Construction is planned to start in Q3 2026, pending the securing of $31.6 million in additional funding.